Cipher Pharmaceuticals Inc. Celebrates Record 152% Revenue Surge in Q2 2025
Cipher Pharmaceuticals Inc. has reported a record 152% increase in revenue for Q2 2025, driven by strong sales of its product Natroba and strategic debt reduction efforts.
2 minutes to read